Eli Lilly Archives - Pharmaphorum

Teva slumps after Express Scripts funds migraine rivals in US

https://pharmaphorum.com/news/teva-slumps-after-express-scripts-funds-migraine-rivals-in-us/

Lilly unveils promising data from dual-action diabetes drug

https://pharmaphorum.com/news/lilly-diabetes-unveils-promising-data-from-dual-action-diabetes-drug/

Lilly’s breast cancer drug Verzenio approved in EU

https://pharmaphorum.com/news/lillys-breast-cancer-drug-verzenio-approved-in-eu/

Novo to market ‘connected’ insulin pens next year

https://pharmaphorum.com/news/novo-to-market-connected-insulin-pens-next-year/

Lilly pushes into migraine market as Emgality approved in US

https://pharmaphorum.com/news/lilly-pushes-into-migraine-market-as-emgality-approved-in-us/

FDA approves Teva’s migraine drug, decision due on Lilly’s rival

https://pharmaphorum.com/news/fda-approves-tevas-migraine-drug-decision-due-on-lillys-rival/

Adocia and Lilly’s legal tussle intensifies as diabetes deal goes wrong

https://pharmaphorum.com/news/adocia-illy-legal-tussle-intensifies/

Novo’s oral semaglutide on target in phase 3 trial

https://pharmaphorum.com/news/novos-oral-semaglutide-target-phase-3-trial/

Regeneron/Teva pain drug fasinumab on target in phase 3

https://pharmaphorum.com/news/regeneron-teva-pain-drug-fasinumab-target-phase-3/

Search